Cancer Research KI

Karolinska Institutet and Karolinska University Hospital are the first institutions in Sweden to be accredited as a Comprehensive Cancer Centre by the Organisation of European Cancer Institutes (OECI). The accreditation means that KI and Karolinska University Hospital attain the highest standards in all aspects of the cancer field, from care, prevention, diagnosis, treatment and rehabilitation to research, teaching and education.

Are you curious about commercialization and implementation and would like to learn more about the possibilities of how your research could be explored to benefit the patients? If so, this Mentor4 Research program can be for you! KI Innovations AB will run a mentorship program for oncology and stem cells and regenerative medicine researchers at KI in collaboration with Cancer Research KI and StratRegen. 

Deadline: 1st October 2020

The grants serve as seed funding with aim to encourage KI and University Hospital-based researchers to join forces around one major group of cancers. Each of the task forces was formed to promote interdisciplinary, interdepartmental and translational cooperation. The task forces include all levels of research from bench to bedside, involving basic scientists, nursing scientists, epidemiologists, oncologists, surgeons and other clinicians. 

Submission deadline: 30 September, 2020

The Mayo Clinic Cancer Center and Karolinska Institutet are pleased to announce the 2020 Request for Applications (RFA) within the area of breast cancer. Having created a unique network, Mayo Clinic Cancer Center and Karolinska Institutet are in an excellent position to leverage this relationship to make a global impact on cancer through research focusing on the diagnosis, prevention, or treatment of breast cancer.

Submission deadline has passed feedback to applicants in fall 2020

Cancer Research KI launched two opportunities to apply for research funding in the area of cancer research. The first call named 'Blue Sky Grant', which has also been launched previously, is a “high risk – high reward” type of funding, while the second call named 'Translational Seed Funding' is a new program for novel collaborations between basic and clinical scientists in the area of translational cancer research.

Feedback to applicants: fall 2020

This 3-day VIRTUAL conference is a forum where MD Anderson Cancer Center and its global network of hospitals, health systems and research institutions collaborate to develop impactful, innovative ideas and research that help MD Anderson achieve its mission.

Joint workshop between Cancer Research KI and RCC Stockholm-Gotland will aim to address opportunities for interaction and communication between patient organisations, researchers and the general public. 

The XIXth Cancer Research KI Retreat takes place September 27-28, 2021 at Djurönäset in the Stockholm archipelago, gathering Cancer Researchers from Karolinska Institutet and University Hospital for an annual joint scientific meeting.